RCRebecca L. Clements

Rebecca L. Clements

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rebecca L. Clements has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Kellie Ann Jurado

    Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, 19104, United States of America

    3 shared publications
  • Taylor Miller-Ensminger

    Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA

    3 shared publications
  • Christopher A. Hunter

    Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania

    2 shared publications
  • Sneha Mani

    Department of Obstetrics and Gynecology, Hospital at the University of Pennsylvania, Philadelphia, USA

    2 shared publications
  • Alexander A. Morano

    Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115

    1 shared publication
  • Alexandra H. Lopez

    Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA

    1 shared publication

Latest Publications

  • Open Access

    Interleukin-27 is antiviral against Zika virus at the maternal-fetal interface

    by Madeline S. Merlino, Briah Barksdale, Seble G. Negatu, Drake T. Philip, Rebecca L. Clements, Taylor Miller-Ensminger, Alexandra H. Lopez, Sneha Mani, Monica N. Mainigi, Christopher A. Hunter, et al.

    Congenital viral infections can have severe consequences for pregnancy and fetal outcomes. Remarkably, the fetal-derived placenta serves as a robust barrier to infection through meticulous regulation by immune effectors and cytokines. Yet, the regulatory roles of many cytokines remain undefined at the maternal-fetal interface, including Interleukin-27 (IL-27). Here, we show that trophoblast organoids derived from human placentas constitutively express both IL-27 and its receptor, and restrict Zika virus infection through IL-27 signaling. Through bulk RNA-sequencing of trophoblast organoids in the absence and presence of IL-27 signaling, we demonstrate IL-27-mediated upregulation of antiviral genes. Finally, we show that IL-27 signaling is critical to restricting placental viral burdens and protecting against pathologic fetal outcomes during murine congenital Zika virus infection. In this work, we demonstrate a novel role for IL-27 in the placenta and establish IL-27 as an innate antiviral defense at the maternal-fetal interface during congenital viral infection.


  • Open Access

    Interleukin-27 is antiviral at the maternal-fetal interface.

    by Kellie Ann Jurado, Madeline Merlino, Briah Barksdale, Seble Negatu, Rebecca Clements, Taylor Miller-Ensminger, Alexandra Lopez, Sneha Mani, Monica Mainigi, Christopher Hunter

    Congenital viral infections can have severe consequences for pregnancy and fetal outcomes. Remarkably, the fetal-derived placenta serves as a robust barrier to infection through meticulous regulation by immune effectors and a diverse repertoire of cytokines. Yet, the regulatory roles of many cytokines remain undefined at the maternal-fetal interface. Interleukin 27 (IL-27) is a highly expressed cytokine in the placenta whose functional consequence during congenital infection is unknown. Here, we utilized trophoblast organoids (TO) derived from primary human placentas and a mouse model of congenital viral infection to uncover the functional role of IL-27 signaling during pregnancy. We show that TOs constitutively express IL-27 and its receptor, IL27RA, and demonstrate that IL-27 signaling restricts Zika virus (ZIKV) infection of TOs. Through bulk RNA-sequencing of TOs in the absence and presence of IL-27 signaling, we demonstrate IL-27-mediated upregulation of antiviral genes. Finally, we show that IL-27 signaling is critical within the context of congenital murine ZIKV infection, as IL-27 restricts placental ZIKV burdens and protects against pathologic fetal outcomes early in gestation. These findings collectively demonstrate a novel role for IL-27 in the placenta and establish IL-27 as an innate antiviral defense at the maternal-fetal interface during congenital viral infection.

  • Open Access

    Human erythroid progenitors express antigen presentation machinery

    by Rebecca L. Clements, Elizabeth A. Kennedy, David Song, Ariana Campbell, Hyun Hyung An, Kevin R. Amses, Taylor Miller-Ensminger, Mary M. Addison, Laurence C. Eisenlohr, Stella T. Chou, et al.

    Early-life immune exposures can profoundly impact lifelong health. However, functional mechanisms underlying fetal immune development remain incomplete. Erythrocytes are not typically considered active immune mediators, primarily because erythroid precursors discard their organelles as they mature, thus losing the ability to alter gene expression in response to stimuli. Erythroid progenitors and precursors circulate in human fetuses and neonates. Although there is limited evidence that erythroid precursors are immunomodulatory, our understanding of the underlying mechanisms remains inadequate. To define the immunobiological role of fetal and perinatal erythroid progenitors and precursors, we analyzed single cell RNA-sequencing data and found that transcriptomics support erythroid progenitors as putative immune mediators. Unexpectedly, we discovered that human erythroid progenitors constitutively express Major Histocompatibility Complex (MHC) class II antigen processing and presentation machinery, which are hallmarks of specialized antigen presenting immune cells. Furthermore, we demonstrate that erythroid progenitors internalize and cleave foreign proteins into peptide antigens. Unlike conventional antigen presenting cells, erythroid progenitors express atypical costimulatory molecules and immunoregulatory cytokines that direct the development of regulatory T cells, which are critical for establishing maternal-fetal tolerance. Expression of MHC II in definitive erythroid progenitors begins during the second trimester, coinciding with the appearance of mature T cells in the fetus, and is absent in primitive progenitors. Lastly, we demonstrate physical and molecular interaction potential of erythroid progenitors and T cells in the fetal liver. Our findings shed light on a unique orchestrator of fetal immunity and provide insight into the mechanisms by which erythroid cells contribute to host defense.


  • Open Access

    Identification of basal complex protein that is essential for maturation of transmission-stage malaria parasites

    by Rebecca L. Clements, Alexander A. Morano, Francesca M. Navarro, James P. McGee, Esrah W. Du, Vincent A. Streva, Scott E. Lindner, Jeffrey D. Dvorin

    Malaria remains a global driver of morbidity and mortality. To generate new antimalarials, one must elucidate the fundamental cell biology of Plasmodium falciparum , the parasite responsible for the deadliest cases of malaria. A membranous and proteinaceous scaffold called the inner membrane complex (IMC) supports the parasite during morphological changes, including segmentation of daughter cells during asexual replication and formation of transmission-stage gametocytes. The basal complex lines the edge of the IMC during segmentation and likely facilitates IMC expansion. It is unknown, however, what drives IMC expansion during gametocytogenesis. We describe the discovery of a basal complex protein, PfBLEB, which we find to be essential for gametocytogenesis. Parasites lacking PfBLEB harbor defects in IMC expansion and are unable to form mature gametocytes. This article demonstrates a role for a basal complex protein outside of asexual division, and, importantly, highlights a potential molecular target for the ablation of malaria transmission.